Combination therapy of mycophenolate mofetil and FK506 in lupus nephrifis

被引：0
|
作者：
Mahmood, Tariq [1 ]
Fine, Derek [2 ]
Petri, Michelle [2 ]
机构：
[1] St Agnes Hosp, Baltimore, MD USA
[2] Johns Hopkins Univ, Baltimore, MD USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S559 / S560
页数：2
相关论文
共 50 条
  • [21] Different Effects of FK506, Rapamycin, and Mycophenolate Mofetil on Glucose-Stimulated Insulin Release and Apoptosis in Human Islets
    Johnson, James D.
    Ao, Ziliang
    Ao, Peter
    Li, Hong
    Dai, Long-Jun
    He, Zehua
    Tee, May
    Potter, Kathryn J.
    Klimek, Agnieszka M.
    Meloche, R. Mark
    Thompson, David M.
    Verchere, C. Bruce
    Warnockt, Garth L.
    CELL TRANSPLANTATION, 2009, 18 (08) : 833 - 845
  • [22] FK506 nephrotoxicity
    Finn, WF
    RENAL FAILURE, 1999, 21 (3-4) : 319 - 329
  • [23] FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation
    Yamamoto, S
    Okuda, T
    Yamasaki, K
    Tanaka, H
    Kubo, S
    Takemura, S
    Ikeda, K
    Minamiyama, Y
    Hirohashi, K
    Suehiro, S
    TRANSPLANTATION, 2004, 78 (11) : 1618 - 1625
  • [24] FK506 Binding Proteins as Targets in Anticancer Therapy
    Romano, Simona
    Di Pace, AnnaLaura
    Sorrentino, Antonio
    Bisogni, Rita
    Sivero, Luigi
    Romano, Maria Fiammetta
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2010, 10 (09) : 651 - 656
  • [25] HEMOLYTIC UREMIC SYNDROME DURING FK506 THERAPY
    ICHIHASHI, T
    NAOE, T
    YOSHIDA, H
    KIYOI, H
    FUKUTANI, H
    KUBO, K
    YAMAUCHI, T
    SAITO, H
    OHNO, R
    LANCET, 1992, 340 (8810): : 60 - 61
  • [26] FLUCONAZOLE THERAPY IN TRANSPLANT RECIPIENTS RECEIVING FK506
    MANEZ, R
    MARTIN, M
    RAMAN, V
    SILVERMAN, D
    JAIN, A
    WARTY, V
    GONZALEZPINTO, I
    KUSNE, S
    STARZL, TE
    TRANSPLANTATION, 1994, 57 (10) : 1521 - 1523
  • [27] Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis
    Yoshimasu, T
    Ohtani, T
    Sakamoto, T
    Oshima, A
    Furukawa, F
    EUROPEAN JOURNAL OF DERMATOLOGY, 2002, 12 (01) : 50 - 52
  • [28] Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy
    Jones, JW
    Üstüner, ET
    Zdichavsky, M
    Edelstein, J
    Ren, XP
    Maldonado, C
    Ray, M
    Jevans, AW
    Breidenbach, WC
    Gruber, SA
    Barker, JH
    SURGERY, 1999, 126 (02) : 384 - 388
  • [29] PHARMACOKINETICS OF FK506 FOLLOWING ORAL-ADMINISTRATION - A COMPARISON OF FK506 AND CYCLOSPORINE
    VENKATARAMANAN, R
    JAIN, A
    WARTY, VW
    ABUELMAGD, K
    FURAKAWA, H
    IMVENTARZA, O
    FUNG, J
    TODO, S
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 931 - 933
  • [30] INVITRO IMMUNOSUPPRESSIVE EFFECTS OF FK506 IN COMBINATION WITH OTHER DRUGS
    ZEEVI, A
    DUQUESNOY, R
    EIRAS, G
    RABINOWICH, H
    TODO, S
    MAKOWKA, L
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (01) : 220 - 222
12345